When hospital procurement decisions are focused on cost, patients pay the price.

Read Call to Action.

By warding off diseases like influenza and pertussis, immunizations play a critical role in infant and early childhood health. Immunizations protect infants from life-threatening diseases, which can lead to both hospitalization and longterm complications.

Read Position Statement

Why is it important that medications and devices be developed specifically
for infants?

When it comes to medical innovation, not all patients are the same.

Read Interview

A conversation with Donald M. Null, MD.

Q: What is RSV?

Respiratory syncytial virus is a seasonal virus that causes an infection of the lungs. RSV is the leading cause of hospitalization in children younger than one year old.

Read Interview

How are infants affected by COVID-19?

Dr. S: NICUs are starting to see babies born to COVID-positive mothers. Some of these babies may also test positive. The mothers are sick, but many times the babies have no symptoms. These babies still require isolation and one-on-one staffing. No visitors. Generally you see infants and children contracting COVID less frequently and not having as difficult a time with it as older adults do. One theory says that may be because of all the vaccinations young children receive. Their immune systems are bolstered.

Read the Interview

A national data supplier provided palivizumab claims for Medicaid and commercial health plans across the nation from January 2019 through December 2019.

• Health plans deny 40% of palivizumab prescriptions for premature infants born between 29 and 36 weeks gestation.

• One in every four prescriptions is denied for infants who should qualify for coverage under standard insurance policies.

Read Report Card

Watch Karen Crowley, DNP, Jeffereson Jones, MD, MPH, and Bob Hopkins, MD, give an overview of RSV, new options to prevent it and CDC guidance for their use, and resources for providers and patients/caregivers.

Watch Webinar

This survey briefing discusses the indirect impact and burden of RSV on babies, young children, their families and the health care providers who treat young RSV patients. Two surveys were conducted, one of parents who had at least one child contract RSV, and one of pediatric health care providers who treat babies and young children with RSV.

Watch webinar

Respiratory syncytial virus, also known as RSV, is a seasonal virus that affects nearly all infants and children before they are two years old.

Watch the Video

General pediatrician Lynn Smitherman, MD, explains how the burden of RSV weighs heavily on babies, children and their families.

Watch the Video

Suzanne Staebler, DNP unpacks new data showing that vulnerable infants are denied access to preventive treatment for RSV.

Listen Here

It's Respiratory Syncytial Virus season. Do you know the signs? Shanisty Ireland didn't when her six-week-old son Adam contracted the disease. In this episode, Shanisty recalls her family's RSV experience, while Mitchell Goldstein, MD, of the National Coalition for Infant Health shares key risk factors and signs parents should look for.

Listen Here